| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9080 |
| Human Intestinal Absorption | HIA+ | 0.9333 |
| Caco-2 Permeability | Caco2- | 0.6448 |
| P-glycoprotein Substrate | Non-substrate | 0.8964 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9323 |
| Non-inhibitor | 0.9954 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9442 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4648 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8246 |
| CYP450 2D6 Substrate | Non-substrate | 0.8284 |
| CYP450 3A4 Substrate | Non-substrate | 0.7604 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8662 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8555 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9145 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8640 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9886 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9650 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7724 |
| Non-inhibitor | 0.9337 |
| AMES Toxicity | Non AMES toxic | 0.8646 |
| Carcinogens | Carcinogens | 0.8323 |
| Fish Toxicity | Low FHMT | 0.7029 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7580 |
| Honey Bee Toxicity | High HBT | 0.7693 |
| Biodegradation | Ready biodegradable | 0.5873 |
| Acute Oral Toxicity | III | 0.6748 |
| Carcinogenicity (Three-class) | Non-required | 0.6637 |